CD39 is a marker for T cell exhaustion and even though it was recently reported to be induced in terminally exhausted CD8+ T cells by tumor hypoxia (75), there are other features in hypoxic TMEs such as abnormal tumor vasculature and increased fibrosis, which mediate T cell exclusion (70). This evidence concerns the gene ENTPD1 and neoplasm.